TLDR: Hyro, a leading platform for Responsible AI Agents in healthcare, has successfully raised $45 million in a strategic growth funding round. This investment, led by Healthier Capital, brings Hyro’s total funding to $95 million and aims to accelerate the deployment and development of AI agents designed to streamline patient access and operational efficiencies across the healthcare sector.
NEW YORK – October 21, 2025 – Hyro, a pioneer in Responsible AI Agent Platforms tailored for the healthcare industry, today announced the successful closure of a $45 million strategic growth funding round. This significant investment is set to propel the company’s mission to enhance patient access and operational performance through advanced AI agent technology.
The funding round was spearheaded by Healthier Capital, with notable participation from existing investors Norwest and Define Ventures. The round also saw new strategic investments from Bon Secours Mercy Health, a long-standing client of Hyro, and ServiceNow Ventures, the investment arm of ServiceNow. This latest capital infusion comes just ten months after Hyro’s previous funding round, effectively doubling the company’s valuation and bringing its total funding to an impressive $95 million.
The newly secured capital will be instrumental in fast-tracking Hyro’s development of sophisticated administrative, operational, and clinical AI agents. These agents are designed to revolutionize healthcare consumer access across various digital and voice channels, addressing critical industry challenges such as staff shortages, burnout, and attrition.
Hyro’s platform is already deployed at scale across more than 45 prominent health systems, facilitating interactions for over 30 million patients across the United States. Recent additions to its client roster include major healthcare providers like Sutter Health, Tampa General Hospital, Prisma Health, and Piedmont Healthcare. The platform’s adoption is also expanding rapidly among health plans and mid-sized specialty and clinic groups.
Amir Dan Rubin, CEO & Founding Managing Partner of Healthier Capital, commented on the investment, stating, “Hyro is delivering better levels of access, experience, and operational performance to leading healthcare organizations, delivering significant returns-on-investment.” This sentiment underscores the industry’s growing confidence in Hyro’s innovative approach.
Hyro’s technological foundation combines the flexibility of Large Language Models (LLMs) with its proprietary conversational engine, which includes specialized Small Language Models (SLMs) for healthcare organizations, and advanced knowledge graphs purpose-built for the sector. This hybrid architecture empowers Hyro’s AI agents to accurately resolve up to 85% of routine patient interactions, encompassing tasks such as registration, routing, scheduling, and prescription management, all while maintaining strict compliance with HIPAA and other robust healthcare standards.
Also Read:
- League Introduces AI-Powered Agent Teams for Continuous, Personalized Healthcare Experiences
- OpenEvidence Secures $200 Million Series C, Propelling Valuation to $6 Billion Amidst Rapid AI Adoption in Healthcare
Building on its robust foundation, Hyro recently introduced Proactive Px™, an expansion of its platform designed to cover 360-degree, bi-directional communications. This new offering enables both inbound and outbound interactions, proactively meeting patients’ needs. The company’s solutions are critical in an era where patient expectations demand instant, digital-first access to care, and AI is rapidly reshaping interactions across call centers, websites, mobile apps, and SMS.
